左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议-2019

2019-10-30 中华医学会心血管病学分会 中国心脏起搏与心电生理杂志.2019.33(5):385-401.

自2014年由中华医学会心电生理和起搏分会、中华医学会心血管病分会、中国医师协会心律学专业委员会组织国内相关专家撰写的《左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议》以来的近五年间,国内外有关左心耳(LAA)干预预防心房颤动(简称房颤)患者血栓栓塞事件的基础与临床研究成果不断问世,其研究结果进一步奠定了干预LAA预防房颤患者血栓栓塞事件的理论基础;进一步提升了干预LAA 预防房颤患者血

中文标题:

左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议-2019

发布日期:

2019-10-30

简要介绍:

自2014年由中华医学会心电生理和起搏分会、中华医学会心血管病分会、中国医师协会心律学专业委员会组织国内相关专家撰写的《左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议》以来的近五年间,国内外有关左心耳(LAA)干预预防心房颤动(简称房颤)患者血栓栓塞事件的基础与临床研究成果不断问世,其研究结果进一步奠定了干预LAA预防房颤患者血栓栓塞事件的理论基础;进一步提升了干预LAA 预防房颤患者血栓栓塞事件的重要性认识和临床实践质量。 近年来,国内开展经LAA干预预防房颤患者血栓栓塞事件的中心越来越多,其从业人员迅速扩大,被干预病人数增速较快,此为累积经验、深化研究、提升认识进一步奠定了基础,但也为同质化管理、优化管理质量提出了严峻挑战。有鉴于此,中华医学会心电生理和起搏分会、中国医师协会心律学专业委员会组织相关专家在2014年发表的《共识》基础上,结合国内外的研究成果和参考《2019AHA/ACC/HRS Focused Update of the 2014AHA/ACC/HRS Guideline for the management of patients with Atrial Fibrillation》章节,撰写了《LAA干预预防心房颤动血栓栓塞事件:目前的认识和建议-2019》,现予发表,以供参考。

 

拓展指南:房颤相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=999219, encodeId=a32d9992193a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Tue Jul 13 22:19:31 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967978, encodeId=ce8496e978e1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2945461880, createdName=ms6000002014406310, createdTime=Sun May 23 18:35:13 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889008, encodeId=3efd8890088b, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d085148054, createdName=1468e278m76暂无昵称, createdTime=Mon Sep 28 21:54:47 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882797, encodeId=948d882e97af, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Fri Sep 04 21:24:29 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882097, encodeId=664d88209e65, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2e25206552, createdName=1474e843m09暂无昵称, createdTime=Wed Sep 02 08:47:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2021-07-13 139173a1c0m

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=999219, encodeId=a32d9992193a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Tue Jul 13 22:19:31 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967978, encodeId=ce8496e978e1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2945461880, createdName=ms6000002014406310, createdTime=Sun May 23 18:35:13 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889008, encodeId=3efd8890088b, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d085148054, createdName=1468e278m76暂无昵称, createdTime=Mon Sep 28 21:54:47 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882797, encodeId=948d882e97af, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Fri Sep 04 21:24:29 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882097, encodeId=664d88209e65, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2e25206552, createdName=1474e843m09暂无昵称, createdTime=Wed Sep 02 08:47:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2021-05-23 ms6000002014406310

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=999219, encodeId=a32d9992193a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Tue Jul 13 22:19:31 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967978, encodeId=ce8496e978e1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2945461880, createdName=ms6000002014406310, createdTime=Sun May 23 18:35:13 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889008, encodeId=3efd8890088b, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d085148054, createdName=1468e278m76暂无昵称, createdTime=Mon Sep 28 21:54:47 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882797, encodeId=948d882e97af, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Fri Sep 04 21:24:29 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882097, encodeId=664d88209e65, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2e25206552, createdName=1474e843m09暂无昵称, createdTime=Wed Sep 02 08:47:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-28 1468e278m76暂无昵称

    学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=999219, encodeId=a32d9992193a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Tue Jul 13 22:19:31 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967978, encodeId=ce8496e978e1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2945461880, createdName=ms6000002014406310, createdTime=Sun May 23 18:35:13 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889008, encodeId=3efd8890088b, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d085148054, createdName=1468e278m76暂无昵称, createdTime=Mon Sep 28 21:54:47 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882797, encodeId=948d882e97af, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Fri Sep 04 21:24:29 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882097, encodeId=664d88209e65, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2e25206552, createdName=1474e843m09暂无昵称, createdTime=Wed Sep 02 08:47:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-04 逆行星

    谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=999219, encodeId=a32d9992193a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220129/c7c88b72da034b4ebf8facad24333d58/6b7d298fb5b542f8a29b221866c2d53d.jpg, createdBy=6c211431876, createdName=139173a1c0m, createdTime=Tue Jul 13 22:19:31 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967978, encodeId=ce8496e978e1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2945461880, createdName=ms6000002014406310, createdTime=Sun May 23 18:35:13 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889008, encodeId=3efd8890088b, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d085148054, createdName=1468e278m76暂无昵称, createdTime=Mon Sep 28 21:54:47 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882797, encodeId=948d882e97af, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/04/7d4e27c5834b1a3e4b408bbcc7a5d2c5.jpg, createdBy=e51d5325936, createdName=逆行星, createdTime=Fri Sep 04 21:24:29 CST 2020, time=2020-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882097, encodeId=664d88209e65, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2e25206552, createdName=1474e843m09暂无昵称, createdTime=Wed Sep 02 08:47:10 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-02 1474e843m09暂无昵称

    学习

    0